Bulk materials to be registered during approval process for finished drugs.

Published: 1999-04-24 18:20:00

Updated: 1999-04-24 18:20:00

Having learned from the bitter experience with Ferritin incidence the KFDA plans to intensify drug quality controls over the whole processes from the production and purchasing of bulk materials to the manufacture of finished drugs.
The KFDA concluded that the quality of finished drugs be well e...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK